Secondary outcome measures include daily energy expenditure in physical activity, daily caloric intake, percent of participants losing ≥5% of baseline body weight, and stages of motivational readiness for physical activity and diet changes.
Both CT and PET responses were individually significantly associated with survival duration; but in the multifactor analysis, this included the known prognostic factors of CT response, performance status, weight loss, and stage; only the PET response was significantly associated with the duration of survival (p < 0.0001) [ 12].
All values are weighted for the sampling weight, cluster weight and multi stage sampling.
We addressed this issue by using weighted analysis and complex sample analysis in SPSS to adjust for sample weight, and multi stage sampling.
Conversely, females show high variability in weight at first maturity and no clear relationship between total weight and maturity stage.
BMC, BMAD, BMDspine, and L2L4BMDvol were adjusted for confounding factors such as age, gender, BMI, height, weight, and pubertal stage.
Study design: Children and adolescents with SCA (n = 68), aged 5 to 16 years at baseline, reached the maximum tolerated dose and had serial height, weight, and Tanner stage measurements.
But the weight and development stage was highly associated as presented in Table 1.
DXA scans, height, weight and pubertal stage were assessed according to a standardized procedure at the same day and location.
